A Randomized Phase II Study of Two Doses of Interferon Alfa-2a (IFN Alfa-2a) in Combination With Zidovudine (AZT) and Dideoxycytidine (ddC) Versus AZT and ddC Only in Patients With HIV Infection and Less Than 400 CD4 Cells/mm3

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

Not specified

Study Completion Date

February 28, 1995

Conditions

HIV Infections

Interventions

DRUG

Interferon alfa-2a

DRUG

Zidovudine

DRUG

Zalcitabine

Trial Locations (4)

Alabama Therapeutics CRS, Birmingham

Ucsd, Avrc Crs, La Jolla

UCSD Maternal, Child, and Adolescent HIV CRS, San Diego

Univ. of Miami AIDS CRS, Miami